Key Clinical Formulas & Scores
Eye: 4=spontaneous, 3=to speech, 2=to pain, 1=none
Verbal: 5=oriented, 4=confused, 3=inappropriate, 2=incomprehensible, 1=none
Motor: 6=obeys, 5=localizes, 4=withdraws, 3=flexion, 2=extension, 1=none
GCS โค8 = severe brain injury โ airway protection (intubation)
GCS 9-12 = moderate, GCS 13-15 = mild
H = History (highly suspicious=2, moderately=1, non-suspicious=0)
E = ECG (significant ST depression=2, non-specific=1, normal=0)
A = Age (โฅ65=2, 45-64=1, <45=0)
R = Risk factors (โฅ3 or known CAD=2, 1-2=1, 0=0)
T = Troponin (โฅ3x normal=2, 1-3x=1, <1x=0)
0-3: Low risk (0.9-1.7% MACE) โ early discharge
4-6: Intermediate (12-16.6%) โ observation, serial troponins
7-10: High risk (50-65%) โ admit, early invasive strategy
Predicts serious cause within 30 days
Points: Clinical judgement low risk=-3, pre-syncope=-1
Clinical predictors: (each -1 to +2)
โข Trauma: +1
โข Male sex: +1
โข Acute coronary syndrome history: +2
โข Valvular heart disease: +2
โข Signs of CHF: +2
โข Shortness of breath: +1
โข SBP <90: +2
Score: โค-3 = low risk (0.4%), -2 to 0 = low-intermediate (2.2%), โฅ1 = high risk (7.5%)
X-ray needed if ANY of:
โข Bone tenderness at posterior edge of distal 6 cm of tibia
โข Bone tenderness at posterior edge of distal 6 cm of fibula
โข Inability to bear weight (4 steps) both immediately and in ED
Sensitivity: ~97-100% (misses 1-3% of fractures)
Sensitivity ~97-100% for clinically significant ankle fractures
Specificity: ~40-50% (reduces X-rays by ~30-40%)
1. Acute onset + skin/mucosal involvement + respiratory compromise or hypotension
2. Acute onset + โฅ2 of: skin/mucosal, respiratory, hypotension, GI symptoms
3. Hypotension after exposure to known allergen
Treatment: IM epinephrine 0.3-0.5 mg (1:1000) anterolateral thigh โ FIRST LINE
Adjuncts: H1 blocker (diphenhydramine), H2 blocker (ranitidine), corticosteroids, IV fluids
Observation: 4-6 hours (biphasic reaction risk)
Core Concepts
ACLS Cardiac Arrest Algorithm
Shockable rhythms (VF/pulseless VT): CPR โ defibrillation (200J biphasic) โ CPR 2 min โ epinephrine 1mg IV/IO q3-5min โ shock โ CPR 2 min โ amiodarone 300mg IV โ shock โ CPR 2 min โ epinephrine โ shock โ amiodarone 150mg โ continue. Non-shockable (PEA/asystole): CPR โ epinephrine q3-5min โ search for reversible causes (H's and T's: Hypovolemia, Hypoxia, H+/Hypo-Hyperkalemia, Hypothermia, Tension pneumothorax, Tamponade, Toxins, Thrombosis (pulmonary/coronary)). Post-ROSC: targeted temperature management (32-36ยฐC ร 24h), hemodynamic optimization, coronary angiography if STEMI.
Trauma Assessment (ATLS)
Primary survey (ABCDE): Airway (with c-spine protection), Breathing (ventilation), Circulation (hemorrhage control, 2 large-bore IVs), Disability (GCS, pupils), Exposure (undress completely, prevent hypothermia). Secondary survey: head-to-toe exam, AMPLE history (Allergies, Medications, Past medical history, Last meal, Events). FAST exam (Focused Assessment with Sonography in Trauma): free fluid in Morrison's pouch, splenorenal, pelvis, pericardium. Resuscitative thoracotomy for penetrating thoracic trauma with signs of life. Damage control surgery for severe hemorrhage (permissive hypotension, massive transfusion protocol 1:1:1 ratio).
Toxicology: Common Overdoses & Antidotes
Acetaminophen: N-acetylcysteine (NAC) within 8-10 hours (Rumack-Matthew nomogram). Opioids: naloxone 0.4-2 mg IV (short half-life, may need infusion). Benzodiazepines: flumazenil (generally contraindicated โ seizure risk). Beta-blockers/CCB: glucagon, high-dose insulin, calcium. Tricyclic antidepressants: sodium bicarbonate (QRS >100). Organophosphates: atropine + pralidoxime. Cyanide: hydroxocobalamin. Iron: deferoxamine. Warfarin: 4-factor PCC (KCentra), vitamin K.
Clinical Case Studies
Case 1: STEMI with Cardiogenic Shock
Patient: 62-year-old male, severe crushing chest pain ร 1 hour, diaphoretic, hypotensive. BP 82/50, HR 110, cool extremities, JVD, crackles bilaterally. ECG: ST elevation V1-V4, II, III, aVF. Troponin 45 ng/mL.
Diagnosis: Acute extensive STEMI with cardiogenic shock (Killip IV).
Management: (1) Aspirin 325mg, ticagrelor 180mg, heparin bolus. (2) Emergent cardiac cath lab activation (door-to-balloon <90 min). (3) Vasopressors: norepinephrine for MAP <65. (4) Intra-aortic balloon pump (IABP) or Impella for mechanical support if deteriorating. (5) PCI to culprit vessel (likely LAD + RCA/LCx multivessel). (6) Post-PCI: ICU, inotropic support (dobutamine), monitor for complications (arrhythmias, mechanical complications).
Case 2: Severe Sepsis from Pyelonephritis
Patient: 45-year-old female, fever 39.8ยฐC, rigors, left flank pain, confusion ร 12 hours. PMH: diabetes. BP 82/50, HR 130, RR 28, SpOโ 90%. Lactate 4.8. UA: cloudy, WBC>100, nitrites+. CXR: clear.
Diagnosis: Septic shock from urosepsis (pyelonephritis). qSOFA = 3.
Management: (1) 30 mL/kg crystalloid bolus (3000 mL NS within 3 hours). (2) Blood cultures ร 2, then piperacillin-tazobactam 4.5g IV within 1 hour. (3) Norepinephrine for MAP <65 after fluids. (4) Supplemental Oโ, maintain SpOโ โฅ94%. (5) Urinary catheter for output monitoring (target >0.5 mL/kg/hr). (6) CT abdomen/pylvis to exclude obstruction/perinephric abscess if no improvement in 24-48 hours. (7) ICU admission.
Case 3: Opioid Overdose
Patient: 22-year-old male found unresponsive, cyanotic, RR 4/min, pinpoint pupils. Bystander reports heroin use. GCS 3 (E1 V1 M1).
Diagnosis: Opioid overdose with respiratory depression.
Management:
Practice Questions
A: Low risk (0.9-1.7% MACE). May be considered for early discharge with outpatient follow-up and stress testing within 72 hours, provided serial troponins are negative and ECG shows no dynamic changes.
A: Massive transfusion protocol activation (1:1:1 ratio of PRBC:FFP:platelets) and emergent exploratory laparotomy. This is hemorrhagic shock โ needs immediate source control in the OR. Permissive hypotension (target SBP 80-90) until hemorrhage controlled.
A: IM epinephrine 0.3-0.5 mg (1:1000 concentration) in the anterolateral thigh. Repeat q5-15 minutes if needed. Never give IV epinephrine except in cardiac arrest or severe refractory anaphylaxis under continuous monitoring.
A: Patients with bone tenderness at the posterior edge of the distal 6 cm of the tibia or fibula, or inability to bear weight (4 steps) both immediately and in the ED. Misses only ~1-3% of fractures, reducing unnecessary X-rays by 30-40%.
A: H's: Hypovolemia, Hypoxia, H+ (acidosis), Hypo/Hyperkalemia, Hypothermia. T's: Tension pneumothorax, Tamponade (cardiac), Toxins, Thrombosis (pulmonary embolism), Thrombosis (coronary), Trauma.